Australas J Dermatol February 2013 PMID 22686691

Combination therapy with finasteride and low-dose dutasteride in the treatment of androgenetic alopecia.

Ann Boyapati, Rodney Sinclair

Download social card

Mentions

Peak: 1 in Jul 2021

across 3 sources since Jul 2021

Extended reach

135,341

potential audience

Total likes

2,864

Video views

133,758

Mentions per month

Jul 2021 – Aug 2024

Where it's discussed

YouTube4 videos
Reddit2 posts
X / Twitter1 posts

AI synopsis

What people are saying

Comments reflect a general endorsement of combining finasteride and low-dose dutasteride for hair loss, with phrases like 'significant increase in hair density' and mention of 'treatment outcomes,' showing some understanding and interest. The tone and wording suggest a hopeful outlook on the treatment's effectiveness, but without extensive technical debate, indicating a moderate level of engagement and impact.

AgreementModerate agreement

Most discussions show support or curiosity about the combination therapy's potential benefits, indicating moderate agreement with the article's findings.

InterestModerate interest

The discussions reflect a moderate level of interest, mentioning the treatment and its implications but without deep technical analysis.

EngagementModerate engagement

Commenters reference the treatment strategy and share personal or anecdotal experiences, indicating an engaged but not highly technical audience.

ImpactModerate impact

The conversations suggest the topic might influence patient choices or clinical considerations, but the overall impact appears moderate given the limited scope of discussion.

Abstract in brief

A 47-year-old man with androgenetic alopecia initially treated with finasteride experienced reduced effectiveness over time.
The addition of low-dose dutasteride (0.5 mg/week) alongside ongoing finasteride treatment led to a significant increase in hair density.
The case suggests that combining finasteride and dutasteride can enhance treatment outcomes for patients not fully responding to finasteride alone.]

Read the full abstract